ArticleNature biomedical engineering2022

Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker.

Aslan Mansurov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.